Cargando…
AMPed up to treat prostate cancer: novel AMPK activators emerge for cancer therapy
Despite recent advances in the treatment for metastatic prostatic adenocarcinoma, clinical management of this tumor type remains a major challenge, and there is as of yet no durable cure for advanced disease. Developing pathways that could be co-targeted alongside the androgen receptor or that would...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Blackwell Publishing Ltd
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992071/ https://www.ncbi.nlm.nih.gov/pubmed/24562461 http://dx.doi.org/10.1002/emmm.201303737 |